Portfolio expansion consolidates Controllab among the largest providers

Portfolio expansion consolidates Controllab among the largest providers


The company stands out as a full solution operating in several segments, serving from human to environmental analysis.

Throughout its trajectory of more than 40 years, Controllab acts with the objective of seeding quality and is committed to taking care of life. This history is based on the commitment to offer complete and integrated solutions in terms of quality and assertiveness of laboratory results.

The services provided by Controllab facilitate the routine for laboratory accreditation processes and regulatory bodies in the broadest portfolio on the market, with more than 3,500 tests.

This diversity is constantly expanded to provide laboratories with the greatest possible coverage of quality control, helping them to provide precise and undisputed services to stand out in the national and international markets.

The company pioneered controls for Covid-19 and carried out several initiatives that support these routines. “It was challenging to develop quality control for Covid-19 while the sector itself learned with the diagnosis of the disease”, explains Jessica Gomes, Research and Development manager at Controllab

“With the advance of research and knowledge about SARS-CoV2, we continue to improve the quality control to monitor the diagnostic evolution of the virus, but in this period other exams have advanced and these analyzes need to be controlled” adds the Manager.

In view of the impacts on the care of life, Controllab provides control for multiple segments. It serves the clinical, blood bank, veterinary, microbiology and physical-chemical tests areas for medicines, food, sanitizing, water and effluents, fuel and others, among services that serve from hospitals to industries.

A careful look at analytical movements is in line with Controllab’s vision of offering services and technologies for quality control, providing reliability for laboratories and security for citizens.

All tests offered by Controllab follow the criteria of ABNT NBR ISO/IEC 17043. By participating in the Proficiency Testing, the laboratory can evidence the accuracy of the analyzes and the reliability of the results issued in its routine. Check out Controllab’s initiatives in the first half of the year, which expanded the human microbiological and physical-chemical analysis segments.

Human Segment

ensaio de proficiencia en 3

MicroscopyEosinophils ResearchDigitized cases for eosinophils research in three matrices: nasal mucus, urine and feces
ManualManual HematologyHematocrit, Hemoglobin and Red Cell, Leukocyte and Platelet Count by Neubauer chamber and Nageotte chamber
TLR / Point of Care (POC)RDT – Point of Care (POC) Bone Marrow/Growth Markers – Serum25 (OH) Vitamin D
RDT – Point of Care (POC) Tumor Markers IIAlpha fetoprotein
RDT – Point of Care (POC) Coagulation IIFibrinogen, Activated Coagulation Time (ACT), Prothrombin Time, Thrombin Time (TT) and Activated Partial Thromboplastin Time (TTPa) – time
Biología MolecularDetection of Streptococcus A groupDetection of Streptococcus A group
Detection of Escherichia coliDetection of Escherichia coli
Detection of Giardia sp.Detection of Giardia sp.
Detection of Acinetobacter baumanniiDetection of Acinetobacter baumannii
Detection of CandidaDetection of Candida sp., C. albicans, C. kruzei, C. parapsilosis, C. auris, C. tropicalis, C. glabata e C. guilhermondi
Clostridium difficile: Molecular Biologystrain BI/NAP1/027
Molecular Biology Mycobacterium tuberculosisResistance to isoniazid (INH)
Sequencing: Detection of Bacterial GenomeDetection of bacterial genome by sequencing
Sequencing: Detection Fungi and Yeasts GenomeDetection of fungi and yeast genome by sequencing
Sequencing: Neonatal ScreeningComplete sequencing for identification of disorders and diseases in the newborn
RDT – Point of Care (POC) Molecular Respiratory Syncytial Virus (RSV)RSV detection in RDT systems / Point of Care (POC)
Covid-19Neutralizing Antibodies Research to Covid-19Neutralizing Antibodies Research to Covid-19 in automated systems
RDT – Point of Care (POC) Neutralizing Antibodies Research: Coronavirus (SARS-CoV2)Research for Covid-19 Neutralizing Antibodies in RDT systems / Point of Care (POC)
RDT Molecular Coronavirus (SARS-CoV2)Detection of SARS-CoV2 in RDT systems / Point of Care (POC)
AutomatizaciónDrugs of Abuse: hair/furKetamine
Drugs of Abuse: salivaAlprazolam, Bromazepam and Flurazepam
Autoimmunity IAnti-Ana
ThromboelastogramMaximum Lysis

Physical And Chemical Analysis

ensaio de proficiencia en 3

FoodsWheat FlourDetermination of Humidity, Granulometry and Total Fat
SaltDetermination of Iodine in the form of Iodate, in the form of Iodide and humidity
HoneyDetermination of humidity
Olive OilSpecific Extinction
Fruit JuiceDetermination of sorbitol
Oils and FatsDetermination of soaps in vegetable oils
EnvironmentWater and EffluentsTotal and Fixed Solids

Microbiological Analysis

ensaio de proficiencia en 3

MedicinesMedicinesResearch of Clostridia Reducing Sulphite and Clostridium perfringens
CosmeticsCosmeticsResearch of Clostridia and Clostridium perfringens
EnvironmentWater for InjectablesTotal count of heterotrophic bacteria
Search for total and fecal coliforms
Search for Pseudomonas aeruginosa

Sign up for our newsletter

Receive relevant publications about lab and solutions for quality management.
We use cookies and other similar technologies to improve your experience, enabling a more personalized navigation, according to the characteristics and your interest. For more information see our Privacy and Security Policy.

PRM 0009

Accreditation Cgcre/Inmetro - Certified Reference Material Producer

Controllab has been accredited as a Certified Reference Material Producer (MRC) since 2016 by Inmetro’s General Coordination for Accreditation (CGCRE), under the PMR 0009 number. The assessment of this conformity is carried out according to the requirements established in ABNT NBR standards ISO 17034 and Inmetro, thus ensuring competence for the production of MRCs, according to the Scope of Accreditation.
Cgcre is signatory to the Mutual Recognition Arrangements of the International Laboratory Accreditation Cooperation (ILAC) and Interamerican Accreditation Cooperation (IAAC).

CAL 0214

Accreditation Cgcre/Inmetro - Calibration Laboratory

In December 2002, the Calibration Laboratory was accredited by Inmetro’s General Coordination for Accreditation (CGCRE). With this recognition, it became an integral part of the Brazilian network of accredited laboratories, under nº214. Since then, it is periodically evaluated for the maintenance and/or extension of accreditation.

Cgcre is signatory to the Mutual Recognition Arrangements of the International Laboratory Accreditation Cooperation (ILAC) and Interamerican Accreditation Cooperation (IAAC).

PEP 0003

Accreditation Cgcre/Inmetro - Proficiency Test Provider

In September 2011, Controllab was accredited by Inmetro’s General Coordination for Accreditation (CGCRE) as a proficiency test provider, under nº PEP0003. Initially as part of a pilot project by Inmetro, this accreditation was based on ILAC G13: 2007 and included several clinical and hemotherapy tests. In the periodic evaluations of this accreditation, new segments and tests are included and the evaluation is now conducted according to ABNT NBR ISO/IEC 17043.

This accreditation attests to Controllab’s technical competence to develop and conduct proficiency tests in accordance with international requirements and enables it to be recognized in other countries, in accordance with mutual recognition agreements signed by Brazil in Mercosur, the Americas and Europe.

Cgcre is signatory to the Mutual Recognition Arrangements of the International Laboratory Accreditation Cooperation (ILAC) and Interamerican Accreditation Cooperation (IAAC).